Patient and infection characteristics | Bacterial phenotype | Total 131 studies | |||
---|---|---|---|---|---|
A. baumannii 53 studies | P. aeruginosa 7 studies | Enterobacteriaceae 51 studies | Mixed Gram- negative 20 studies | ||
Age years, median (IQR) (103 studies provided data) | 57 (51–65) | 59.5 (46–63) | 60 (51–64) | 59.5 (51–65) | 59.5 (51–65) |
Pulmonary illness | 20 (10–26) | 19 (15–28) | 16 (10–23) | 21 (12–25) | 20 (11–26) |
Median frequency % (IQR) (64 studies provided data) | |||||
Neurological illness | 13 (8–22) | – | 22 (9–24) | 20 (11–28) | 17 (9–26) |
Median frequency % (IQR) (36 studies provided data) | |||||
Renal illness | 23 (18–35) | 23 (20–35) | 24.5 (22–36) | 20 (18–33) | 22 (18–35) |
Median frequency % (IQR) (76 studies provided data) | |||||
Immunocompromised status | 26 (14–44) | 31 (15–41) | 29.5 (18–47) | 32 (15–43) | 26 (14–40) |
Median frequency % (IQR) (72 studies provided data) | |||||
Infection type, n (%) | |||||
Mixed infection | 18 (35) | 4 (57) | 31 (61) | 11 (57) | 64 (49) |
Bloodstream infection | 13 (24) | 0 | 18 (35) | 6 (28.5) | 37 (28) |
Ventilator−/Hospital acquired pneumonia | 20 (37) | 3 (43) | 2 (4) | 2 (9.5) | 27 (21) |
Othera | 2 (4) | 0 | 0 | 1 (5) | 3 (2) |
Apache II score | 18 (15–22) | 14 (14–16) | 20 (15–21) | 19 (19–23) | 20 (17–23) |
Median (IQR) (76 studies provided data) | |||||
Monomicrobial, n (%) (79 studies provided data) | 13 (26) | 3 (43) | 12 (23) | 6 (27) | 34 (26) |
Appropriate empiric treatment° | – | – | – | – | 48 (22–67) |
Median frequency % (IQR)b (30 studies provided data) |